ATE429435T1 - 7h-pyrrolopyrimidinderivate - Google Patents

7h-pyrrolopyrimidinderivate

Info

Publication number
ATE429435T1
ATE429435T1 AT05715376T AT05715376T ATE429435T1 AT E429435 T1 ATE429435 T1 AT E429435T1 AT 05715376 T AT05715376 T AT 05715376T AT 05715376 T AT05715376 T AT 05715376T AT E429435 T1 ATE429435 T1 AT E429435T1
Authority
AT
Austria
Prior art keywords
derivatives
preparation
pharmaceutical compositions
pyrrolopyrimidine derivatives
pyrrolo
Prior art date
Application number
AT05715376T
Other languages
English (en)
Inventor
Giorgio Caravatti
Andrea Vaupel
Original Assignee
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Pharma Gmbh filed Critical Novartis Pharma Gmbh
Application granted granted Critical
Publication of ATE429435T1 publication Critical patent/ATE429435T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT05715376T 2004-02-18 2005-02-17 7h-pyrrolopyrimidinderivate ATE429435T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0403606.7A GB0403606D0 (en) 2004-02-18 2004-02-18 Organic compounds
PCT/EP2005/001635 WO2005077951A2 (en) 2004-02-18 2005-02-17 7h-pyrrolopyrimidine derivatives

Publications (1)

Publication Number Publication Date
ATE429435T1 true ATE429435T1 (de) 2009-05-15

Family

ID=32039961

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05715376T ATE429435T1 (de) 2004-02-18 2005-02-17 7h-pyrrolopyrimidinderivate

Country Status (16)

Country Link
US (1) US7625894B2 (de)
EP (1) EP1718651B1 (de)
JP (1) JP2007523115A (de)
KR (1) KR20060124705A (de)
CN (1) CN1922184A (de)
AT (1) ATE429435T1 (de)
AU (1) AU2005212832B2 (de)
BR (1) BRPI0507811A (de)
CA (1) CA2553889A1 (de)
DE (1) DE602005014087D1 (de)
ES (1) ES2322814T3 (de)
GB (1) GB0403606D0 (de)
PL (1) PL1718651T3 (de)
PT (1) PT1718651E (de)
RU (1) RU2006133264A (de)
WO (1) WO2005077951A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0821209A2 (pt) 2007-12-19 2019-09-24 Amgen Inc composto, composição farmacêutica, métodos de tratar câncer, para reduzir o tamanho de tumor, para tratar distúrbios, e para reduzir metástase em um tumor.
WO2009126584A1 (en) 2008-04-07 2009-10-15 Amgen Inc. Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitors
ES2543569T3 (es) 2011-03-23 2015-08-20 Amgen Inc. Inhibidores duales tricíclicos condensados de CDK 4/6 y FLT3
MX2015002887A (es) * 2012-09-06 2015-07-06 Plexxikon Inc Compuestos y metodos para la modulacion de cinasas, e indicaciones para ello.
EP2970201B1 (de) * 2013-03-11 2019-06-19 Merck Patent GmbH 6-[4-(1h-imidazol-2-yl)piperidin-1-yl]pyrimidin-4-amin-verbindungen als modulatoren der kinase aktivität
WO2014145576A2 (en) 2013-03-15 2014-09-18 Northwestern University Substituted pyrrolo(2,3-d)pyrimidines for the treatment of cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE217873T1 (de) * 1996-01-23 2002-06-15 Novartis Erfind Verwalt Gmbh Pyrrolopyrimidinen und verfahren zu deren herstellung
AU720429B2 (en) * 1996-08-23 2000-06-01 Novartis Ag Substituted pyrrolopyrimidines and processes for their preparation
TR199902301T2 (xx) * 1997-03-19 1999-12-21 Basf Aktiengesellschaft Pirilo $2,3D]pirimidinler ve onlar�n kullan�m�.
PA8474101A1 (es) 1998-06-19 2000-09-29 Pfizer Prod Inc Compuestos de pirrolo [2,3-d] pirimidina
GB0119249D0 (en) * 2001-08-07 2001-10-03 Novartis Ag Organic compounds
AU2002349013A1 (en) 2001-10-29 2003-05-12 Novartis Ag Use of 7h-pyrrolo(2,3-d)pyrimidine derivatives in the treatment of solid tumor diseases
US7253166B2 (en) * 2003-04-22 2007-08-07 Irm Llc 6-phenyl-7H-pyrrolo[2,3-d]pyrimidine compounds that induce neuronal differentiation in embryonic stem cells
US20050239806A1 (en) * 2004-01-13 2005-10-27 Ambit Biosciences Corporation Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases
PE20051092A1 (es) * 2004-01-29 2006-01-20 Novartis Ag Derivados de pirrolo-pirimidina utiles para el tratamiento de enfermedades proliferativas

Also Published As

Publication number Publication date
PL1718651T3 (pl) 2009-09-30
AU2005212832A1 (en) 2005-08-25
CN1922184A (zh) 2007-02-28
JP2007523115A (ja) 2007-08-16
AU2005212832B2 (en) 2009-11-05
RU2006133264A (ru) 2008-04-10
DE602005014087D1 (de) 2009-06-04
CA2553889A1 (en) 2005-08-25
GB0403606D0 (en) 2004-03-24
PT1718651E (pt) 2009-07-17
US7625894B2 (en) 2009-12-01
BRPI0507811A (pt) 2007-07-10
US20070135460A1 (en) 2007-06-14
WO2005077951A3 (en) 2006-03-02
ES2322814T3 (es) 2009-06-29
KR20060124705A (ko) 2006-12-05
EP1718651B1 (de) 2009-04-22
EP1718651A2 (de) 2006-11-08
WO2005077951A2 (en) 2005-08-25

Similar Documents

Publication Publication Date Title
GB0119249D0 (en) Organic compounds
BR0312573A (pt) Derivados de fenil-[4-(3-fenil-1h-pirazol-4-il)-pirimidin-2-il]-amina
GB0022438D0 (en) Organic Compounds
DE602004024375D1 (de) Carboxamidderivate
TW200615266A (en) Organic compounds
SE0401971D0 (sv) Piperidne derivatives
MY143795A (en) Tetrahydropyridoindole derivatives
DE602006014579D1 (de) Heteroalkylgebundene pyrimidinderivate
NZ543661A (en) Pyrazolo-quinazoline derivatives having antitumor activity and process for their preparation
ATE470443T1 (de) Indol-1-yl-essigsäurederivate
SE0401342D0 (sv) Therapeutic compounds
TW200510392A (en) Chemical compounds
MY135850A (en) Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
BRPI0413438A (pt) derivados de pirimidilpirrol ativos como inibidores de cinase
TW200505452A (en) Chemical compounds
PL2185561T3 (pl) Pochodne 1,2,3,4-tetrahydropirolo(1,2-a)pirazyno-6-karboksamidów i 2,3,4,5-tetrahydropirolo(1,2-a)-diazepino-7-karboksamidów, ich wytwarzanie i zastosowanie terapeutyczne
DK1869038T3 (da) Substituerede 5,6,7,8-tetrahydro-imidazol[1,2-a]pyridin-2-ylamin-forbindelser og deres anvendelse til fremstilling af lægemidler
TW200626581A (en) Compounds, compositions containing them, preparation thereof and uses thereof
ATE429435T1 (de) 7h-pyrrolopyrimidinderivate
WO2004108094A3 (en) Sulfonamide-substituted chalcone derivatives and their use to treat diseases
ZA200605653B (en) Proline derivatives used as pharmaceutical active ingredients for the treatment of tumours
NO20060045L (no) Indolederivater med apoptoseinduserende effekt
TW200621750A (en) Compounds, compositions containing them, preparation thereof and uses thereof
TW200626582A (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
TW200616970A (en) Compounds, compositions containing them, preparation thereof and uses thereof

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1718651

Country of ref document: EP

REN Ceased due to non-payment of the annual fee